Assessment of adherence to oral antipsychotic medications: what has changed over the past decade?
DI Velligan, NJ Maples, JJ Pokorny, C Wright - Schizophrenia research, 2020 - Elsevier
Introduction In a previous review, spanning 3 decades, we found that self-report and other
non-objective measures were the primary means of assessing adherence to oral …
non-objective measures were the primary means of assessing adherence to oral …
Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
R Sruamsiri, K Iwasaki, W Tang, J Mahlich - BMC dermatology, 2018 - Springer
Abstract Background Biological therapies (BTs) including infliximab (IFX), adalimumab
(ADL), secukinumab (SCK) and ustekinumab (UST) are approved in Japan for the treatment …
(ADL), secukinumab (SCK) and ustekinumab (UST) are approved in Japan for the treatment …
Estimating prevalence and healthcare utilization for treatment-resistant depression in Japan: a retrospective claims database study
J Mahlich, S Tsukazawa, F Wiegand - Drugs-Real World Outcomes, 2018 - Springer
Abstract Background Major depressive disorders (MDDs) including treatment-resistant
depression (TRD) are common disabling conditions, but data on their epidemiology in …
depression (TRD) are common disabling conditions, but data on their epidemiology in …
Computer-assisted cognitive remediation therapy in schizophrenia: Durability of the effects and cost-utility analysis
G Garrido, R Penadés, M Barrios, N Aragay, I Ramos… - Psychiatry …, 2017 - Elsevier
The durability of computer–assisted cognitive remediation (CACR) therapy over time and the
cost-effectiveness of treatment remains unclear. The aim of the current study is to investigate …
cost-effectiveness of treatment remains unclear. The aim of the current study is to investigate …
Time to treatment discontinuation in German patients with schizophrenia: long-acting injectables versus oral antipsychotics
J Mahlich, K Olbrich, A Wilk, A Wimmer… - Clinical drug …, 2021 - Springer
Abstract Background and Objective Long-acting injectable antipsychotics (LAIs) are
associated with better treatment adherence and persistence than oral antipsychotics (OAPs) …
associated with better treatment adherence and persistence than oral antipsychotics (OAPs) …
Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study
C Miyazaki, R Sruamsiri, J Mahlich… - Journal of Medical …, 2020 - Taylor & Francis
Aim: To describe the characteristics and medication treatment patterns, healthcare resource
utilization (HRU), and associated costs in Japanese patients with systemic lupus …
utilization (HRU), and associated costs in Japanese patients with systemic lupus …
Effect of adding individualized occupational therapy to standard care on rehospitalization of patients with schizophrenia: A 2‐year prospective cohort study
T Shimada, M Ohori, Y Inagaki… - Psychiatry and …, 2019 - Wiley Online Library
Aim We examined the effect of individualized occupational therapy (IOT) compared to the
usual group occupational therapy (GOT) on the rehospitalization of patients with …
usual group occupational therapy (GOT) on the rehospitalization of patients with …
[HTML][HTML] Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study
E Kanda, N Morita, T Yajima - Frontiers in Physiology, 2023 - frontiersin.org
Introduction: Hyperkalemia (HK) is a common disorder in patients with heart failure or
chronic kidney disease, and potassium binders (PBs) are recommended to control serum …
chronic kidney disease, and potassium binders (PBs) are recommended to control serum …
Delay in psychiatric hospitalization from the diagnosis of first-episode schizophrenia and its association with clinical outcomes and direct medical costs: a nationwide …
Background Early intervention is essential for improving the prognosis in patients with first-
episode schizophrenia (FES). The Mental Health Act limits involuntary hospitalization in …
episode schizophrenia (FES). The Mental Health Act limits involuntary hospitalization in …
Drug utilization of Japanese patients diagnosed with schizophrenia: an administrative database analysis
S Cheung, Y Hamuro, J Mahlich, T Nakahara… - Clinical Drug …, 2017 - Springer
Background and objective Patient characteristics require consideration for optimal treatment
in order to achieve clinical remission for an improved quality of life and social functioning …
in order to achieve clinical remission for an improved quality of life and social functioning …